About 76Bio
76Bio is a private company based in Boston, Massachusetts, incorporated in 2020 in Delaware. It has reported $22,225,844 raised in two offerings on Form D since January 2022.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 6, 2023 | Feb 13, 2023amended Feb 14, 2023 | $12,220,600fully sold | 32 | $381K | Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 22, 2021 | Jan 10, 2022 | $10,005,244fully sold | 44 | $227K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $22,225,844 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on 76Bio's Form D filed Feb 14, 2023.
CW
Christopher Wilfong
Executive officer, director and promoter
DT
David Tanen
Secretary and director
AK
Angela Koehler
Director